HEADER TRANSFERASE 24-JUL-08 3DXP TITLE CRYSTAL STRUCTURE OF A PUTATIVE AMINOGLYCOSIDE PHOSPHOTRANSFERASE TITLE 2 (REUT_A1007) FROM RALSTONIA EUTROPHA JMP134 AT 2.32 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE ACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RALSTONIA EUTROPHA JMP134; SOURCE 3 ORGANISM_COMMON: ALCALIGENES EUTROPHUS; SOURCE 4 ORGANISM_TAXID: 264198; SOURCE 5 GENE: YP_295230.1, REUT_A1007; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PROTEIN KINASE-LIKE FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3DXP 1 REMARK SEQADV REVDAT 5 24-JUL-19 3DXP 1 REMARK LINK REVDAT 4 25-OCT-17 3DXP 1 REMARK REVDAT 3 23-MAR-11 3DXP 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3DXP 1 VERSN REVDAT 1 12-AUG-08 3DXP 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE ACYL-COA DEHYDROGENASE JRNL TITL 2 (YP_295230.1) FROM RALSTONIA EUTROPHA JMP134 AT 2.32 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 17366 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 898 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.32 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1257 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.4500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2563 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 96 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.58000 REMARK 3 B22 (A**2) : -3.53000 REMARK 3 B33 (A**2) : 7.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.390 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.280 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.254 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.451 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2670 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1799 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3628 ; 1.479 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4356 ; 0.939 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 336 ; 2.946 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;29.020 ;23.415 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 420 ;12.922 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;12.686 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 381 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3025 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 569 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 657 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1820 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1333 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1262 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 84 ; 0.169 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.165 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 4 ; 0.128 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 14 ; 0.166 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.039 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1733 ; 1.720 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 673 ; 0.277 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2644 ; 2.776 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1141 ; 4.271 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 980 ; 5.791 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION REMARK 3 3. CALCIUM, ACETATE AND 1,2-ETHANEDIOL WERE MODELED BASED REMARK 3 ON CRYSTALLIZATION AND CRYOPROTECTION CONDITIONS. REMARK 3 4. DUE TO A STRONG ICE RING, 991 REFLECTIONS BETWEEN REMARK 3 2.656-2.586 ANGSTROMS WERE OMITTED FROM THE FINAL REFINEMENT. REMARK 3 5. THERE ARE TWO REGIONS OF UNMODELED DENSITY IN THE SOLVENT REMARK 3 STRUCTURE NEAR AMINO ACIDS A90 AND A94. REMARK 3 6. RESIDUES A267 AND A268 ARE RAMACHANDRAN OUTLIERS IN A REGION REMARK 3 WHERE THE ELECTRON DENSITY IS DIFFICULT TO INTERPRET. REMARK 4 REMARK 4 3DXP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.17 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.97971,0.97956 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18395 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 28.989 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : 0.12900 REMARK 200 FOR THE DATA SET : 5.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.71800 REMARK 200 R SYM FOR SHELL (I) : 0.71800 REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% POLYETHYLENE GLYCOL 8000, 0.3M REMARK 280 CALCIUM ACETATE, 0.1M MES PH 6.17, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.04400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.76100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.04400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 63.76100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN. THE PROTOMER MAY FORM A DIMER REMARK 300 BASED ON CRYSTAL PACKING ANALYSIS. SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 62.08800 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 127.52200 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 ASN A 4 REMARK 465 VAL A 5 REMARK 465 SER A 6 REMARK 465 HIS A 7 REMARK 465 PHE A 8 REMARK 465 GLU A 9 REMARK 465 GLY A 10 REMARK 465 THR A 11 REMARK 465 ARG A 12 REMARK 465 PRO A 13 REMARK 465 VAL A 14 REMARK 465 ALA A 15 REMARK 465 ASP A 16 REMARK 465 GLN A 17 REMARK 465 GLN A 18 REMARK 465 GLY A 48 REMARK 465 PRO A 71 REMARK 465 LYS A 72 REMARK 465 SER A 73 REMARK 465 LYS A 74 REMARK 465 LEU A 75 REMARK 465 LEU A 76 REMARK 465 PRO A 77 REMARK 465 SER A 78 REMARK 465 ALA A 79 REMARK 465 HIS A 80 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 19 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 46 CG CD CE NZ REMARK 470 ARG A 114 CZ NH1 NH2 REMARK 470 LYS A 169 CD CE NZ REMARK 470 ARG A 176 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 183 CD CE NZ REMARK 470 LYS A 186 CD CE NZ REMARK 470 GLN A 205 CD OE1 NE2 REMARK 470 GLN A 209 CG CD OE1 NE2 REMARK 470 GLN A 334 CD OE1 NE2 REMARK 470 ASP A 337 CG OD1 OD2 REMARK 470 LYS A 340 CE NZ REMARK 470 ARG A 341 CD NE CZ NH1 NH2 REMARK 470 LYS A 357 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 37 114.55 -168.43 REMARK 500 SER A 50 -73.68 65.15 REMARK 500 ALA A 67 -158.99 -99.91 REMARK 500 ALA A 104 142.69 -170.36 REMARK 500 ILE A 112 -6.17 -140.60 REMARK 500 ASP A 241 75.92 38.17 REMARK 500 THR A 246 -166.47 -171.02 REMARK 500 GLN A 267 109.36 77.09 REMARK 500 PHE A 268 101.58 69.77 REMARK 500 SER A 332 141.95 -32.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 359 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 226 OD1 REMARK 620 2 ASP A 241 OD2 75.4 REMARK 620 3 HOH A 453 O 80.3 67.0 REMARK 620 4 HOH A 454 O 80.3 136.0 73.1 REMARK 620 5 HOH A 455 O 111.2 97.4 158.4 125.7 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 361 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 387040 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3DXP A 1 358 UNP Q473P7 Q473P7_RALEJ 1 358 SEQADV 3DXP GLY A 0 UNP Q473P7 EXPRESSION TAG SEQRES 1 A 359 GLY MSE SER SER ASN VAL SER HIS PHE GLU GLY THR ARG SEQRES 2 A 359 PRO VAL ALA ASP GLN GLN ARG PHE ASP THR GLU ALA LEU SEQRES 3 A 359 GLU ALA TRP MSE ARG GLN HIS VAL GLU GLY PHE ALA GLY SEQRES 4 A 359 PRO LEU SER VAL GLU GLN PHE LYS GLY GLY GLN SER ASN SEQRES 5 A 359 PRO THR PHE LYS LEU VAL THR PRO GLY GLN THR TYR VAL SEQRES 6 A 359 MSE ARG ALA LYS PRO GLY PRO LYS SER LYS LEU LEU PRO SEQRES 7 A 359 SER ALA HIS ALA ILE GLU ARG GLU TYR ARG VAL MSE ASP SEQRES 8 A 359 ALA LEU ALA GLY THR ASP VAL PRO VAL ALA LYS MSE TYR SEQRES 9 A 359 ALA LEU CYS GLU ASP GLU SER VAL ILE GLY ARG ALA PHE SEQRES 10 A 359 TYR ILE MSE GLU PHE VAL SER GLY ARG VAL LEU TRP ASP SEQRES 11 A 359 GLN SER LEU PRO GLY MSE SER PRO ALA GLU ARG THR ALA SEQRES 12 A 359 ILE TYR ASP GLU MSE ASN ARG VAL ILE ALA ALA MSE HIS SEQRES 13 A 359 THR VAL ASP TYR GLN ALA ILE GLY LEU GLY ASP TYR GLY SEQRES 14 A 359 LYS PRO GLY ASN TYR PHE GLN ARG GLN ILE GLU ARG TRP SEQRES 15 A 359 THR LYS GLN TYR LYS LEU SER GLU THR GLU SER ILE PRO SEQRES 16 A 359 ALA MSE ASP SER LEU MSE ASP TRP LEU PRO GLN HIS ILE SEQRES 17 A 359 PRO GLN GLU ASP ALA ASP LEU THR SER ILE VAL HIS GLY SEQRES 18 A 359 ASP TYR ARG LEU ASP ASN LEU MSE PHE HIS PRO THR GLU SEQRES 19 A 359 PRO ARG VAL LEU ALA VAL LEU ASP TRP GLU LEU SER THR SEQRES 20 A 359 LEU GLY HIS PRO MSE GLY ASP PHE GLY TYR HIS CYS MSE SEQRES 21 A 359 SER TRP HIS ILE ALA PRO GLY GLN PHE ARG GLY ILE ALA SEQRES 22 A 359 GLY LEU ASP HIS ALA ALA LEU GLY ILE PRO ASP GLU ALA SEQRES 23 A 359 SER TYR ARG LYS LEU TYR GLU GLN ARG THR GLY ARG PRO SEQRES 24 A 359 ILE THR GLY ASP TRP ASN PHE TYR LEU ALA PHE SER MSE SEQRES 25 A 359 PHE ARG ILE ALA GLY ILE LEU GLN GLY ILE MSE LYS ARG SEQRES 26 A 359 VAL VAL ASP GLY THR ALA SER SER ALA GLN ALA LEU ASP SEQRES 27 A 359 ALA GLY LYS ARG ALA ARG PRO MSE ALA GLU MSE GLY TRP SEQRES 28 A 359 GLU TYR ALA LYS LYS ALA LYS GLN MODRES 3DXP MSE A 29 MET SELENOMETHIONINE MODRES 3DXP MSE A 65 MET SELENOMETHIONINE MODRES 3DXP MSE A 89 MET SELENOMETHIONINE MODRES 3DXP MSE A 102 MET SELENOMETHIONINE MODRES 3DXP MSE A 119 MET SELENOMETHIONINE MODRES 3DXP MSE A 135 MET SELENOMETHIONINE MODRES 3DXP MSE A 147 MET SELENOMETHIONINE MODRES 3DXP MSE A 154 MET SELENOMETHIONINE MODRES 3DXP MSE A 196 MET SELENOMETHIONINE MODRES 3DXP MSE A 200 MET SELENOMETHIONINE MODRES 3DXP MSE A 228 MET SELENOMETHIONINE MODRES 3DXP MSE A 251 MET SELENOMETHIONINE MODRES 3DXP MSE A 259 MET SELENOMETHIONINE MODRES 3DXP MSE A 311 MET SELENOMETHIONINE MODRES 3DXP MSE A 322 MET SELENOMETHIONINE MODRES 3DXP MSE A 345 MET SELENOMETHIONINE MODRES 3DXP MSE A 348 MET SELENOMETHIONINE HET MSE A 29 8 HET MSE A 65 8 HET MSE A 89 8 HET MSE A 102 8 HET MSE A 119 8 HET MSE A 135 8 HET MSE A 147 8 HET MSE A 154 8 HET MSE A 196 8 HET MSE A 200 8 HET MSE A 228 8 HET MSE A 251 8 HET MSE A 259 8 HET MSE A 311 8 HET MSE A 322 8 HET MSE A 345 8 HET MSE A 348 8 HET CA A 359 1 HET ACT A 360 4 HET EDO A 361 4 HETNAM MSE SELENOMETHIONINE HETNAM CA CALCIUM ION HETNAM ACT ACETATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 17(C5 H11 N O2 SE) FORMUL 2 CA CA 2+ FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 EDO C2 H6 O2 FORMUL 5 HOH *96(H2 O) HELIX 1 1 ASP A 21 VAL A 33 1 13 HELIX 2 2 ALA A 81 ALA A 93 1 13 HELIX 3 3 SER A 136 VAL A 157 1 22 HELIX 4 4 ASN A 172 GLU A 189 1 18 HELIX 5 5 ILE A 193 LEU A 203 1 11 HELIX 6 6 PRO A 204 HIS A 206 5 3 HELIX 7 7 ARG A 223 ASP A 225 5 3 HELIX 8 8 HIS A 249 CYS A 258 1 10 HELIX 9 9 MSE A 259 HIS A 262 5 4 HELIX 10 10 ASP A 275 GLY A 280 1 6 HELIX 11 11 ASP A 283 GLY A 296 1 14 HELIX 12 12 ASP A 302 ASP A 327 1 26 HELIX 13 13 SER A 332 ARG A 341 1 10 HELIX 14 14 ARG A 341 ALA A 356 1 16 SHEET 1 A 5 SER A 41 GLN A 44 0 SHEET 2 A 5 THR A 53 VAL A 57 -1 O VAL A 57 N SER A 41 SHEET 3 A 5 THR A 62 ARG A 66 -1 O TYR A 63 N LEU A 56 SHEET 4 A 5 PHE A 116 GLU A 120 -1 O MSE A 119 N VAL A 64 SHEET 5 A 5 MSE A 102 CYS A 106 -1 N CYS A 106 O PHE A 116 SHEET 1 B 2 SER A 216 VAL A 218 0 SHEET 2 B 2 THR A 246 GLY A 248 -1 O THR A 246 N VAL A 218 SHEET 1 C 2 LEU A 227 PHE A 229 0 SHEET 2 C 2 VAL A 236 VAL A 239 -1 O LEU A 237 N MSE A 228 LINK C TRP A 28 N MSE A 29 1555 1555 1.33 LINK C MSE A 29 N ARG A 30 1555 1555 1.33 LINK C VAL A 64 N MSE A 65 1555 1555 1.33 LINK C MSE A 65 N ARG A 66 1555 1555 1.33 LINK C VAL A 88 N MSE A 89 1555 1555 1.33 LINK C MSE A 89 N ASP A 90 1555 1555 1.34 LINK C LYS A 101 N MSE A 102 1555 1555 1.33 LINK C MSE A 102 N TYR A 103 1555 1555 1.33 LINK C ILE A 118 N MSE A 119 1555 1555 1.33 LINK C MSE A 119 N GLU A 120 1555 1555 1.32 LINK C GLY A 134 N MSE A 135 1555 1555 1.33 LINK C MSE A 135 N SER A 136 1555 1555 1.33 LINK C GLU A 146 N MSE A 147 1555 1555 1.33 LINK C MSE A 147 N ASN A 148 1555 1555 1.33 LINK C ALA A 153 N MSE A 154 1555 1555 1.33 LINK C MSE A 154 N HIS A 155 1555 1555 1.34 LINK C ALA A 195 N MSE A 196 1555 1555 1.33 LINK C MSE A 196 N ASP A 197 1555 1555 1.34 LINK C LEU A 199 N MSE A 200 1555 1555 1.33 LINK C MSE A 200 N ASP A 201 1555 1555 1.33 LINK C LEU A 227 N MSE A 228 1555 1555 1.34 LINK C MSE A 228 N PHE A 229 1555 1555 1.33 LINK C PRO A 250 N MSE A 251 1555 1555 1.33 LINK C MSE A 251 N GLY A 252 1555 1555 1.32 LINK C CYS A 258 N MSE A 259 1555 1555 1.34 LINK C MSE A 259 N SER A 260 1555 1555 1.32 LINK C SER A 310 N MSE A 311 1555 1555 1.33 LINK C MSE A 311 N PHE A 312 1555 1555 1.33 LINK C ILE A 321 N MSE A 322 1555 1555 1.33 LINK C MSE A 322 N LYS A 323 1555 1555 1.33 LINK C PRO A 344 N MSE A 345 1555 1555 1.33 LINK C MSE A 345 N ALA A 346 1555 1555 1.33 LINK C GLU A 347 N MSE A 348 1555 1555 1.33 LINK C MSE A 348 N GLY A 349 1555 1555 1.33 LINK OD1 ASN A 226 CA CA A 359 1555 1555 2.43 LINK OD2 ASP A 241 CA CA A 359 1555 1555 2.27 LINK CA CA A 359 O HOH A 453 1555 1555 2.24 LINK CA CA A 359 O HOH A 454 1555 1555 2.58 LINK CA CA A 359 O HOH A 455 1555 1555 2.42 CISPEP 1 GLY A 38 PRO A 39 0 0.66 SITE 1 AC1 5 ASN A 226 ASP A 241 HOH A 453 HOH A 454 SITE 2 AC1 5 HOH A 455 SITE 1 AC2 4 THR A 141 ASP A 145 PRO A 282 LEU A 290 SITE 1 AC3 3 LEU A 274 ASP A 275 ASN A 304 CRYST1 62.088 127.522 51.509 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016106 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007842 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019414 0.00000